Patients with increased vasostatin levels have a favorable outcome. (A) A threshold of 200 ng/mL separated groups with high vs low serum N-terminus CRT-expressing patients with AML. RFS applying Kaplan-Meier analysis was determined for the 2 groups (P = .0479; median 11.5 vs 7.2 months). (B) OS is depicted for patients with AML consolidated in first complete remission with autologous stem cell transplantation (P = .0057; 23.3 vs 7.5 months).